COMMUNIQUÉS West-GlobeNewswire

Myriad’s BRACAnalysis CDx® Test Effectively Identified Metastatic Breast Cancer Patients with Improved Outcomes from Pfizer's PARP Inhibitor, Talazoparib

12/12/2017 - 13:05

SALT LAKE CITY, Dec. 12, 2017 (GLOBE NEWSWIRE) -- Myriad Genetics , Inc. (NASDAQ: MYGN ), a leader in molecular diagnostics and personalized medicine, today announced that data from the EMBRACA trial showed Myriad’s [...]

Cyclacel Announces Presentation of Results From Phase 3 Seamless Study at Ash Annual Meeting

12/12/2017 - 13:00

BERKELEY HEIGHTS, N.J., Dec. 12, 2017 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC ) (NASDAQ: CYCCP ) "Cyclacel" or the "Company"), a biopharmaceutical company developing oral therapies that target [...]

Tonix Pharmaceuticals Completes Positive Pre-IND Meeting with FDA for TNX-102 SL (Cyclobenzaprine HCI Sublingual Tablets) as a Clinical Candidate for Agitation in Alzheimer’s Disease

12/12/2017 - 13:00

NEW YORK, Dec. 12, 2017 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP ) (Tonix), a company that is developing innovative pharmaceutical and biological products to address public health challenges [...]

P. (Laxmin) Laxminarain Appointed to Microbot Medical’s Board of Directors

12/12/2017 - 13:00

HINGHAM, Mass., Dec. 12, 2017 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT ), a medical device company specializing in the design and development of transformational micro-robotic medical technologies, today [...]

Emergent BioSolutions Awarded Department of National Defence Contract to Supply Anthrasil to the Canadian Government

12/12/2017 - 13:00

GAITHERSBURG, Md., Dec. 12, 2017 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS ) today announced that it has been awarded a contract by the Department of National Defence (DND) valued at approximately $8 [...]

MPX Enters Into Management & Purchase Option Agreements With LMS Wellness, Benefit LLC in Baltimore Maryland

12/12/2017 - 13:00

TORONTO, Dec. 12, 2017 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (the “ Company ” or “ MPX ”) (CSE:MPX) (OTC:MPXEF) today announced that the Company, through its indirect wholly-owned subsidiary, S8 Management, [...]

Zomedica Announces Achievement of Therapeutic Development Milestones

12/12/2017 - 12:55

ANN ARBOR, Mich., Dec. 12, 2017 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V: ZOM ) (“Zomedica” or “Company”), a veterinary pharmaceutical and diagnostic company, today announced a [...]

Repros Therapeutics Inc.® Announces Acquisition by Allergan plc

12/12/2017 - 12:30

THE WOODLANDS, Texas, Dec. 12, 2017 (GLOBE NEWSWIRE) -- Repros Therapeutics Inc. (NASDAQ: RPRX ) (“Repros” or the “Company”) today announced that it has entered into a definitive agreement under which Allergan plc (“ [...]

Pluristem Granted Manufacturer Authorization and Good Manufacturing Practice (GMP) Certification by Israel’s Ministry of Health, Supporting Pivotal-Stage Studies

12/12/2017 - 11:30

Authorization is also under the provision of the Conformity Assessment and Acceptance of Industrial Products (CAA) agreement between Israel and the European Union (EU), which will serve to qualify Pluristem’s facilities [...]

Transactions in relation to share buyback program

12/12/2017 - 11:26

Acting under its share buyback authorization, the GN Store Nord board of directors initiated a share buyback program on May 4, 2017 in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]

Genetic Technologies Provides Update on Strategic Review Initiative

12/12/2017 - 11:00

MELBOURNE, Australia, Dec. 12, 2017 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (NASDAQ: GENE ) (“ Company ”), a molecular diagnostics company focused on cancer risk assessment, and provider of BREVAGen [...]

PsiOxus Therapeutics Receives $15 Million Milestone Payment as Armed Oncolytic Virus Licensed to Bristol-Myers Squibb Achieves CTA

12/12/2017 - 09:00

OXFORD, United Kingdom, Dec. 12, 2017 (GLOBE NEWSWIRE) -- PsiOxus Therapeutics, Ltd. (PsiOxus) today announced that the Clinical Trial Application for NG-348, an “armed” oncolytic virus for the treatment of solid tumors [...]

Operational Update

12/12/2017 - 07:55

SYDNEY, Australia, Dec. 12, 2017 (GLOBE NEWSWIRE) -- Immutep Limited (ASX:IMM) (NASDAQ: IMMP ) (Immutep or the Company), has provided an update on the Company’s two ongoing clinical trials with eftilagimod alpha (LAG- [...]

NEOVACS ANNOUNCES POSITIVE RESULTS OF PRECLINICAL STUDY FOR IFNalpha KINOID IN TYPE 1 DIABETES

12/12/2017 - 07:01

PRESS RELEASE · PRESS RELEASE · PRESS RELEASE NEOVACS ANNOUNCES POSITIVE RESULTS OF PRECLINICAL STUDY FOR IFNalpha KINOID IN TYPE 1 DIABETES Company intends to continue preclinical development in this indication in 2018 [...]

NÉOVACS ANNONCE DES RÉSULTATS POSITIFS POUR SON ÉTUDE PRÉCLINIQUE AVEC l'IFNalpha KINOIDE DANS LE DIABÈTE DE TYPE 1

12/12/2017 - 07:01

COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE NÉOVACS ANNONCE DES RÉSULTATS POSITIFS POUR SON ÉTUDE PRÉCLINIQUE AVEC l'IFNalpha KINOIDE DANS LE DIABÈTE DE TYPE 1 La société poursuivra ce [...]

INNATE PHARMA : UPCOMING INVESTOR CONFERENCES

12/12/2017 - 07:01

upcoming investor conferences Marseille, France, December 12, 2017, 7:00 AM CET Innate Pharma SA (the "Company" - Euronext Paris: FR0010331421 - IPH) today announces that it will be present at the following investor [...]

INNATE PHARMA : PROCHAINS RENDEZ-VOUS INVESTISSEURS

12/12/2017 - 07:01

PROCHAINS RENDEZ-VOUS INVESTISSEURS Marseille, le 12 décembre 2018 Innate Pharma SA (Euronext Paris: FR0010331421 - IPH) annonce aujourd'hui qu'elle sera présente aux événements suivants au cours du premier trimestre [...]

Final Preclinical Asthma Study Confirms Efficacy

12/12/2017 - 01:24

Clear confirmation of efficacy of Cynata’s proprietary Cymerus™ MSCs in second preclinical asthma study Treatment with Cymerus MSCs in clinically-relevant model caused significantly greater reduction of airway [...]

Stephanie Finnegan joins Cromos™ Pharma as Chief Operating Officer, company looks to expand its North American footprint

12/12/2017 - 00:10

PORTLAND, Ore., Dec. 11, 2017 (GLOBE NEWSWIRE) -- Cromos™ Pharma , a premier regional contract research organization announced today that Stephanie Finnegan has been appointed as its Chief Operating Officer. Ms. [...]